Free Trial
→ Everyone’s watching Nvidia right now. Here’s why I’m excited. (From Timothy Sykes) (Ad) Buy DNLI Stock  Free DNLI Stock Alerts

Denali Therapeutics (DNLI) SEC Filings & 10K Form

Denali Therapeutics logo
$13.42 -0.24 (-1.76%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$13.66 +0.23 (+1.75%)
As of 05/23/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Denali Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/17/2025
3:05 PM		Denali Therapeutics (Filer)
Form DEF 14A
04/17/2025
3:06 PM		Denali Therapeutics (Filer)
Form DEFA14A
04/17/2025
3:07 PM		Denali Therapeutics (Filer)
Form ARS
04/17/2025
2:05 PM		BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
04/02/2025
7:02 AM		Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:26 PM		Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM		Denali Therapeutics (Filer)
Form S-3ASR
02/27/2025
3:12 PM		Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM		Denali Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2025
1:14 PM		Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
9:52 AM		BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:03 AM		Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:23 PM		Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM		Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:25 PM		Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM		Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:01 PM		Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:03 PM		Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:06 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:08 PM		Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:10 PM		Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:12 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:14 PM		Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
5:56 PM		Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:57 PM		Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:59 PM		Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:17 PM		Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:18 PM		Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:44 PM		Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:19 PM		Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:55 AM		Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM		Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM		Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
3:11 PM		BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
10/18/2024
3:19 PM		Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
3:37 PM		Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:25 PM		Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:25 PM		Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:26 PM		Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:14 PM		Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
08/22/2024
3:14 PM		Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:15 PM		Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:16 PM		Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
3:40 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:42 PM		Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM		Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM		Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM		Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:27 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
12:18 PM		Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
08/15/2024
3:10 PM		Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
7:36 PM		Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:37 PM		Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
5:52 AM		Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
5:48 AM		Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
8:13 PM		Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:13 PM		Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:38 PM		Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
3:43 PM		Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
7:06 PM		Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:31 PM		Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:32 PM		Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:33 PM		Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:20 PM		Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:27 PM		Denali Therapeutics (Issuer)
Harris Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:28 PM		Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:29 PM		Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:30 PM		Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:30 PM		Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:01 PM		Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:DNLI) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored